ARDELYX, INC. Amortization of Deferred Charges
ARDELYX, INC. (ARDX) reported Amortization of Deferred Charges of $105.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2022-08-04
- ARDELYX, INC. amortization of deferred charges for the quarter ending 2022-06-30 was $58.00K, a 14.71% decline year-over-year.
- ARDELYX, INC. amortization of deferred charges for the quarter ending 2022-03-31 was $47.00K, a 38.96% decline year-over-year.
- ARDELYX, INC. amortization of deferred charges for the quarter ending 2021-12-31 was $48.00K, a 38.46% decline year-over-year.
- ARDELYX, INC. amortization of deferred charges for the quarter ending 2021-09-30 was $47.00K, a 38.96% decline year-over-year.
- ARDELYX, INC. amortization of deferred charges for fiscal 2021 was $240.00K, a 23.32% decline from fiscal 2020.
- ARDELYX, INC. amortization of deferred charges for fiscal 2020 was $313.00K, a 1.29% increase from fiscal 2019.
- ARDELYX, INC. amortization of deferred charges for fiscal 2019 was $309.00K.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 6 month | Amortization of Deferred Charges 9 month | Amortization of Deferred Charges 12 month |
|---|---|---|---|---|
| 2022-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $105.00K 10-Q · filed 2022-08-04 | $153.00K derived: sum of 3 quarters · filed 2022-08-04 | $200.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | $47.00K 10-Q · filed 2022-05-05 | $95.00K derived: sum of 2 quarters · filed 2022-05-05 | $142.00K derived: sum of 3 quarters · filed 2022-05-05 | $210.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $95.00K derived: sum of 2 quarters · filed 2022-02-28 | $163.00K derived: sum of 3 quarters · filed 2022-08-04 | $240.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $115.00K derived: sum of 2 quarters · filed 2022-08-04 | $192.00K 10-Q · filed 2021-11-12 | $270.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $145.00K 10-Q · filed 2022-08-04 | $223.00K derived: sum of 3 quarters · filed 2022-08-04 | $300.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $77.00K 10-Q · filed 2022-05-05 | $155.00K derived: sum of 2 quarters · filed 2022-05-05 | $232.00K derived: sum of 3 quarters · filed 2022-05-05 | $301.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $155.00K derived: sum of 2 quarters · filed 2022-02-28 | $224.00K derived: sum of 3 quarters · filed 2022-02-28 | $313.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $146.00K derived: sum of 2 quarters · filed 2021-11-12 | $235.00K 10-Q · filed 2021-11-12 | $313.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $158.00K 10-Q · filed 2021-08-13 | $236.00K derived: sum of 3 quarters · filed 2022-02-28 | $313.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $89.00K 10-Q · filed 2021-05-06 | $167.00K derived: sum of 2 quarters · filed 2022-02-28 | $244.00K derived: sum of 3 quarters · filed 2022-02-28 | $322.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $155.00K derived: sum of 2 quarters · filed 2022-02-28 | $233.00K derived: sum of 3 quarters · filed 2022-02-28 | $309.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $155.00K derived: sum of 2 quarters · filed 2020-11-05 | $231.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $154.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $76.00K 10-Q · filed 2020-05-07 | |||
| 2018-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $127.00K derived: sum of 2 quarters · filed 2019-11-06 | $177.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $101.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $50.00K 10-Q · filed 2019-05-07 | |||
| 2017-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $96.00K derived: sum of 2 quarters · filed 2018-11-07 | $142.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $91.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $46.00K 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |